Teva Pharmaceutical's total assets for Q1 2026 were $40.04B, a decrease of -1.74% from the previous quarter. TEVA total liabilities were $31.81B for the fiscal quarter, a -3.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.